Nicholas Haft
Fondateur chez Delix Therapeutics, Inc.
Postes actifs de Nicholas Haft
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Delix Therapeutics, Inc.
 Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021. | Directeur/Membre du Conseil | - | - |
| Fondateur | - | - | |
| Directeur Général | - | - | |
| Directeur Financier/CFO | - | - | |
| Secrétaire Général | - | - | |
| Arcos Ventures SPV LLC | Directeur/Membre du Conseil | 01/04/2015 | - |
| Directeur Général | 01/04/2015 | - |
Historique de carrière de Nicholas Haft
Anciens postes connus de Nicholas Haft
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Directeur/Membre du Conseil | 01/02/2020 | 23/06/2023 |
| Independent Dir/Board Member | 01/02/2020 | 23/06/2023 |
Formation de Nicholas Haft
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Health Services | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Entreprise privées | 2 |
|---|---|
Delix Therapeutics, Inc.
Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021. | Health Technology |
| Arcos Ventures SPV LLC |
- Bourse
- Insiders
- Nicholas Haft
- Expérience
